All In MedTech

Device Trial Radar · NCT03030495

Registry of Comprehensive Imaging and Physiological Evaluation of Deferred Lesions Based on FFR

IMaging and Physiologic Predictors of Atherosclerotic Progression in Deferred Lesions With Contemporary Medical Treatment Based on Fractional Flow Reserve-guided Strategy

Last checked: Nov 19, 2026Latest source record: Nov 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

1,400

Planned (sponsor's estimate)

Start

Dec 1, 2016

Primary completion

Dec 31, 2026

Study completion Dec 31, 2026

Sponsor

Lead sponsor
Samsung Medical CenterAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Seoul National University Hospital; Inje University Ilsan Paik Hospital; Ulsan University Hospital; Keimyung University Dongsan Medical Center
First posted
Jan 25, 2017

More device trials from this sponsor

Design

Study type
Observational
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

1. To compare the risk of atherosclerotic lesion progression and subsequent patient-oriented composite outcomes (all-cause mortality, any MI, or any Ischemia-driven repeat revascularization) between deferred lesions with or without over microvascular disease, defined as physiological classification 2. To explore independent predictors of atherosclerotic lesion progression in deferred lesions based on fractional flow reserve-guided strategy and treated by contemporary medical treatment

Conditions

  • Ischemic Heart Disease

Interventions

  • Comprehensive physiologic evaluationDevice

    Comprehensive physiologic evaluation using pressure-temperature sensor wire to measure fractional flow reserve, coronary flow reserve, index of microcirculatory resistance

  • Intravascular imaging devicesDevice

    Intravascular ultrasound or optical coherence tomography

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. patient-oriented composite outcomeTime frame: 24 months

Locations

4 sites in 1 country. Site status is shown where the registry gives one.

  • Keimyung University Dongsan Medical Center

    Daegu, South Korea

  • Inje University Ilsan Paik Hospital

    Goyang-si, South Korea

  • Samsung Medical Center

    Seoul, South Korea

1 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.